[Therapy of headaches. Apropos of 87 cases].
The action of tiapride on headaches has been studied in several neurological departments, both in hospitalized and ambulatory patients. A favourable result was obtained in 63,3% of cases (nearly 2 out of 3). A dosage of 400 mg/day is adequate for an opinion of the efficacy of the product to be made, with the average dosage is about 150 mg/day (1/2 table x 3 times a day). Tolerance  is excellent. Side-effects, wich were noted in 18% of the patients, consist mainly of somnolence and more rarely akathisia. The good results obtained, and the excellent tolerance, enable its use in debilitated alcoholics, the elderly, and those with vascular disorders.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001549:Benzamides / Q000009:adverse effects / Q000627:therapeutic use*; D006970:Disorders of Excessive Somnolence / Q000139:chemically induced; D005260:Female; D005897:Glafenine / Q000627:therapeutic use; D006261:Headache / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged
D001549:Benzamides; D005897:Glafenine
Traitement des céphalées. A propos de 87 observations.